• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多糖基纳米载体用于口服递蛋白/肽的研究进展与展望。

Progress and prospects of polysaccharide-based nanocarriers for oral delivery of proteins/peptides.

机构信息

Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.

Department of Pharmaceutics, College of Pharmacy Sciences, Jilin University, Changchun 130021, China.

出版信息

Carbohydr Polym. 2023 Jul 15;312:120838. doi: 10.1016/j.carbpol.2023.120838. Epub 2023 Mar 24.

DOI:10.1016/j.carbpol.2023.120838
PMID:37059563
Abstract

The oral route has long been recognized as the most preferred route for drug delivery as it offers high patient compliance and requires minimal expertise. Unlike small molecule drugs, the harsh environment of the gastrointestinal tract and low permeability across the intestinal epithelium make oral delivery extremely ineffective for macromolecules. Accordingly, delivery systems that are rationally constructed with suitable materials to overcome barriers to oral delivery are exceptionally promising. Among the most ideal materials are polysaccharides. Depending on the interaction between polysaccharides and proteins, the thermodynamic loading and release of proteins in the aqueous phase can be realized. Specific polysaccharides (dextran, chitosan, alginate, cellulose, etc.) endow systems with functional properties, including muco-adhesiveness, pH-responsiveness, and prevention of enzymatic degradation. Furthermore, multiple groups in polysaccharides can be modified, which gives them a variety of properties and enables them to suit specific needs. This review provides an overview of different types of polysaccharide-based nanocarriers based on different kinds of interaction forces and the influencing factors in the construction of polysaccharide-based nanocarriers. Strategies of polysaccharide-based nanocarriers to improve the bioavailability of orally administered proteins/peptides were described. Additionally, current restrictions and future trends of polysaccharide-based nanocarriers for oral delivery of proteins/peptides were also covered.

摘要

口服途径长期以来被认为是药物输送的首选途径,因为它具有较高的患者顺应性,且所需专业知识较少。与小分子药物不同,胃肠道的恶劣环境和肠道上皮的低通透性使得大分子的口服递送效果极差。因此,采用合适的材料构建合理的输送系统来克服口服递送的障碍具有很大的应用前景。最理想的材料之一是多糖。根据多糖与蛋白质之间的相互作用,可以实现蛋白质在水相中的热力学加载和释放。特定的多糖(葡聚糖、壳聚糖、海藻酸盐、纤维素等)赋予系统多种功能特性,包括黏膜黏附性、pH 响应性和对酶降解的预防。此外,多糖中的多个基团可以被修饰,从而赋予其多种性质,使其能够满足特定需求。本文综述了不同类型的基于多糖的纳米载体,包括基于不同相互作用力的纳米载体和构建基于多糖的纳米载体的影响因素。描述了基于多糖的纳米载体提高口服给予蛋白质/肽的生物利用度的策略。此外,还涵盖了基于多糖的纳米载体用于蛋白质/肽口服递送的当前限制和未来趋势。

相似文献

1
Progress and prospects of polysaccharide-based nanocarriers for oral delivery of proteins/peptides.多糖基纳米载体用于口服递蛋白/肽的研究进展与展望。
Carbohydr Polym. 2023 Jul 15;312:120838. doi: 10.1016/j.carbpol.2023.120838. Epub 2023 Mar 24.
2
Enhancement of Oral Bioavailability of Protein and Peptide by Polysaccharide-based Nanoparticles.多糖纳米粒提高蛋白和多肽的口服生物利用度。
Protein Pept Lett. 2024;31(3):209-228. doi: 10.2174/0109298665292469240228064739.
3
Polysaccharide-based micro/nanocarriers for oral colon-targeted drug delivery.用于口服结肠靶向给药的多糖基微/纳米载体
J Drug Target. 2016 Aug;24(7):579-89. doi: 10.3109/1061186X.2015.1128941. Epub 2016 Jan 14.
4
Materials and structure of polysaccharide-based delivery carriers for oral insulin: A review.基于多糖的口服胰岛素递药载体的材料和结构:综述。
Carbohydr Polym. 2024 Jan 1;323:121364. doi: 10.1016/j.carbpol.2023.121364. Epub 2023 Sep 9.
5
Recent advances of polysaccharide-based nanoparticles for oral insulin delivery.多糖基纳米粒用于口服胰岛素递药的最新进展。
Int J Biol Macromol. 2018 Dec;120(Pt A):775-782. doi: 10.1016/j.ijbiomac.2018.08.152. Epub 2018 Aug 28.
6
Polysaccharide nanoparticles for oral controlled drug delivery: the role of drug-polymer and interpolymer interactions.多糖纳米粒用于口服控释给药:药物-聚合物和聚合物间相互作用的作用。
Expert Opin Drug Deliv. 2020 Oct;17(10):1345-1359. doi: 10.1080/17425247.2020.1789585. Epub 2020 Oct 16.
7
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.口服递呈治疗性肽和蛋白质:基于脂质的纳米载体技术全景。
Adv Drug Deliv Rev. 2022 Mar;182:114097. doi: 10.1016/j.addr.2021.114097. Epub 2022 Jan 7.
8
Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: A review.基于多糖的纳米载体的结肠靶向药物传递用于炎症性肠病的协同治疗:综述。
Carbohydr Polym. 2021 Nov 15;272:118530. doi: 10.1016/j.carbpol.2021.118530. Epub 2021 Aug 4.
9
Breaking the barricade of oral chemotherapy through polysaccharide nanocarrier.多糖纳米载体突破口服化疗难关。
Int J Biol Macromol. 2019 Jun 1;130:34-49. doi: 10.1016/j.ijbiomac.2019.02.094. Epub 2019 Feb 16.
10
Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.双层修饰的中空介孔硅纳米载体克服多重胃肠道屏障。
Acta Biomater. 2018 Jan;65:405-416. doi: 10.1016/j.actbio.2017.10.025. Epub 2017 Oct 14.

引用本文的文献

1
Polymeric nanomaterials as a drug delivery system for anticancer and antibacterial infections: a review.聚合物纳米材料作为抗癌和抗菌感染的药物递送系统:综述
RSC Adv. 2025 Sep 9;15(39):32572-32592. doi: 10.1039/d5ra01788b. eCollection 2025 Sep 5.
2
Effect of Source and Degree of Esterification of High Methoxyl Pectin on Oral Colon-Targeted Multiparticulated Delivery of Otilonium Bromide.高甲氧基果胶的来源和酯化程度对溴化奥替溴铵口服结肠靶向多颗粒递送的影响。
ACS Omega. 2025 Aug 4;10(32):36481-36495. doi: 10.1021/acsomega.5c04979. eCollection 2025 Aug 19.
3
Plant polysaccharide-capped nanoparticles: A sustainable approach to modulate gut microbiota and advance functional food applications.
植物多糖包覆的纳米颗粒:一种调节肠道微生物群并推进功能性食品应用的可持续方法。
Compr Rev Food Sci Food Saf. 2025 Mar;24(2):e70156. doi: 10.1111/1541-4337.70156.
4
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases.代谢性疾病口腔生物大分子疗法的进展
Pharmaceutics. 2025 Feb 12;17(2):238. doi: 10.3390/pharmaceutics17020238.
5
Optimization, physicochemical stability and in vivo study of alginate-chitosan composites as nanocarriers for low molecular weight angiotensin I-converting enzyme (ACE)-inhibitory peptide.藻酸盐-壳聚糖复合材料作为低分子量血管紧张素转换酶(ACE)抑制肽纳米载体的优化、理化稳定性及体内研究
J Food Drug Anal. 2024 Sep 13;32(3):358-370. doi: 10.38212/2224-6614.3522.
6
Enhancement of Oral Bioavailability of Protein and Peptide by Polysaccharide-based Nanoparticles.多糖纳米粒提高蛋白和多肽的口服生物利用度。
Protein Pept Lett. 2024;31(3):209-228. doi: 10.2174/0109298665292469240228064739.
7
Research Progress of Polysaccharide-Gold Nanocomplexes in Drug Delivery.多糖-金纳米复合物在药物递送中的研究进展
Pharmaceutics. 2024 Jan 9;16(1):88. doi: 10.3390/pharmaceutics16010088.
8
Formulation and Evaluation of Insulin-Loaded Sodium-Alginate Microparticles for Oral Administration.用于口服给药的载胰岛素海藻酸钠微粒的制剂与评价
Pharmaceutics. 2023 Dec 28;16(1):46. doi: 10.3390/pharmaceutics16010046.
9
The Current and Promising Oral Delivery Methods for Protein- and Peptide-Based Drugs.蛋白类和肽类药物的现行与有前景的口服递药方法。
Int J Mol Sci. 2024 Jan 9;25(2):815. doi: 10.3390/ijms25020815.
10
Polysaccharide-Based Nanogels to Overcome Mucus, Skin, Cornea, and Blood-Brain Barriers: A Review.基于多糖的纳米凝胶克服黏液、皮肤、角膜和血脑屏障的研究综述
Pharmaceutics. 2023 Oct 23;15(10):2508. doi: 10.3390/pharmaceutics15102508.